Cytokinetics Inc (NASDAQ:CYTK)

PharmTeam (41.35) Submitted: 4/22/2013 8:40:02 PM : Start Price: $1.23 CYTK Score: -11.58

CYTK has two promising drugs that have passed Phase IIa trials with flying colors. Their partnership with Amgen drastically cuts the costs of developing their keystone drug, Omecamtiv Mecarbil, and will yield significant milestone payments should OM continue to exceed expectations.

RBuskey106 (< 20) Submitted: 3/21/2012 8:23:55 PM : Start Price: $1.19 CYTK Score: -22.48

Bio play

ReaperKK (< 20) Submitted: 2/13/2012 10:53:13 AM : Start Price: $1.18 CYTK Score: -26.63

Very specific product that will be promoted at an upcoming 4 conferences over the course of the next 2 months.

redfox18 (99.58) Submitted: 10/13/2011 3:39:49 PM : Start Price: $1.25 CYTK Score: -47.27

Made points in at lower price looking for more

Thleter (65.93) Submitted: 5/24/2011 1:07:51 PM : Start Price: $1.35 CYTK Score: -41.70

Following tenmiles, I like what I saw when doing my initial research. Will be checking up on it more to see if I'm ready to throw down some real coin on it.

tenmiles (99.92) Submitted: 5/12/2011 3:39:38 PM : Start Price: $1.46 CYTK Score: -45.16

Like the risk/reward at $1.47 for at least a trade

marketbeater80 (22.98) Submitted: 2/25/2011 1:14:04 PM : Start Price: $1.51 CYTK Score: -51.07

Bounce play only. Should see 1.70ish IMO.

cheaply (22.03) Submitted: 2/9/2011 4:08:24 PM : Start Price: $1.86 CYTK Score: -65.41

The bottom I hope.

riponfool (40.37) Submitted: 4/28/2010 12:25:32 PM : Start Price: $3.17 CYTK Score: -104.28

it will hit @ $ 10.15

RainierMan (37.20) Submitted: 3/13/2010 1:17:31 PM : Start Price: $3.36 CYTK Score: -111.05

I believe the stock has more or less found a bottom. They have a reasonable amount of cash, and an interesting pipeline. I think the stock will be trend up slowly.

Nmendez10 (< 20) Submitted: 5/30/2009 1:05:16 PM : Start Price: $2.99 CYTK Score: -142.17

Their drug developments and clinical trials are promising. I think they will do better in the future.

PennyStockFool (30.59) Submitted: 12/4/2008 2:57:44 PM : Start Price: $2.01 CYTK Score: +143.02

This one looks like it could be heaed to the scrap heep....

snaphooks (< 20) Submitted: 9/9/2008 11:18:52 PM : Start Price: $4.62 CYTK Score: +114.60

guru short

doneb1 (< 20) Submitted: 2/3/2008 4:59:56 PM : Start Price: $3.73 CYTK Score: -94.53

if even i of its drugs being tested prove successful, it will be a good thing for terminal patients and investors

tharlow (79.13) Submitted: 8/21/2007 3:00:29 AM : Start Price: $4.77 CYTK Score: -97.79

Bargain basement. Giving it away at these prices.

GravityProof (75.02) Submitted: 2/7/2007 11:52:24 PM : Start Price: $8.11 CYTK Score: -108.58

CYTK is undervalued by virtue of its pipeline, trials and tech. While many love other groups perceived to be similar such as EXEL, CYTK will excel (sorry) because of a relative lack of promiscuity between the drugs and their targets.